期刊文献+

脂质体介导hES基因转染人舌鳞癌Tca8113细胞及其蛋白表达 被引量:1

Transfection of Human Endostatin Gene with Lipofectamin and the Expression of hES Protein in Tca8113 Cell
下载PDF
导出
摘要 目的 建立转人内皮抑素 (hES)基因舌鳞癌Tca8113细胞 ,检测体外培养的转基因细胞基因蛋白表达。方法 为了建立携带hES基因的舌鳞癌Tca8113细胞克隆 ,选用阳离子脂质体Lipofectamin为载体 ,将含hES基因的质粒———pBLAST_hES转染Tca8113细胞 ,以BlasticidinS抗生素筛选阳性克隆。免疫组织化学S_P方法检测体外培养的转基因Tca8113细胞克隆中ES的表达。结果 经BlasticidinS抗生素筛选 ,转染hES基因的Tca8113细胞由于具有bsr抗性基因 ,可以在含有 5 0 μg mlBlasticidinS的培养基中生长和传代 ,从而得到携带hES基因的Tca8113细胞克隆。该细胞在体外培养传代 96h后 ,经免疫组织化学检测 ,hES表达的强阳性 (+++)率为 10 0 %。结论 以脂质体介导hES基因转染Tca8113细胞效率高 ,转基因细胞具有高效表达活性目的基因产物的能力。 Objective The purpose of this study was to establish transfergeneic Tca8113 cell and evaluate the expression of human endostatin (hES) gene in the cell colone in vitro.Methods To transfect hES gene into Tca8113 cells, lipofectamin was complexed with plasmid encoding hES gene, and blasticidin S antibiotic was adopted to select Tca8113-hES cell clone. Immunohistochemistry S-P method was adopted to detect the expression of hES in the transfergenic Tca8113 cell in vitro.Results Transfected by hES, the transfergenic Tca8113 cells could grow and proliferate in RPMI-1640 culture medium containing blasticidin S antibiotic. The expression rate of hES reached 100%.Conclusion hES gene can express in hES-transfected Tca8113 cell in vitro.
出处 《华西口腔医学杂志》 CAS CSCD 北大核心 2004年第2期96-99,共4页 West China Journal of Stomatology
基金 国家自然科学基金资助项目 (30 2 71 4 2 3) 广东省医学科学技术研究基金 (2 0 0 3A0 2 5)
关键词 脂质体 hES基因 基因转染 舌鳞癌 TCA8113细胞 蛋白表达 内皮抑素 endostatin gene transfer cell squamous cell carcinama of tongue
  • 相关文献

参考文献3

二级参考文献7

共引文献44

同被引文献11

  • 1潘朝斌,黄洪章,王建广,侯劲松,李海刚.人内皮抑素基因转染对舌鳞癌Tca8113细胞生长的影响[J].中华口腔医学杂志,2004,39(4):273-276. 被引量:4
  • 2[1]O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth [J]. Cell, 1997, 88(2):277-285.
  • 3[2]Nguyen JT, WU P, Clouse ME, et al. Adeno-associated virusmediated delivery of anti angiogenic factors as an antitumor strategy [J]. Cancer Res, 1998, 58(24): 5673-5677.
  • 4[5]Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors [J]. Breast Cancer Res Treat, 1995, 36(2): 169-180.
  • 5[6]Blezinger P, Wang J, Gondo M, et al. Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene [J]. Nat Biotechnol, 1999, 17(4): 343-348.
  • 6[7]Boehn T, Folkman J, Browder T, et al. Antiangiogenesis therapy of experimental cancer dose not induce acquired drug resistance [J].Nature, 1997, 390(6658): 404-407.
  • 7[8]Folkman J. Antiangiogenic gene therapy [J]. Proc Natl Acad Sci 1998, 95(16): 9064-9066.
  • 8[9]Chen QR, Kumar D, Stass SA, et al. Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice [J]. Cancer Res, 1999, 59(14): 3308-3312.
  • 9[10]Szary J, Szala S. Intra-tumoral administration of naked plasmid and encoding mouse endostatin inhibits renal carcinoma growth [J]. Int J Cancer, 2001, 91(6): 835-839.
  • 10[11]Knebelmann B, Dhanabal M, Ramchandran R, et al. Endostatin inhibits VEGF and bFGF induce MAPK activation in endothelial cell [J]. Proc Am Assoc Cancer Res, 1999, 40(45): 414-417.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部